Journal of Applied Pharmacy
Open Access

Improving Patient Outcomes by Managing Chronic Diseases and Drug-Related Challenges

Safieewan Hassan^{* *}Correspondence: Safieewan Hassan, Department of Pharmacology, Ziauddin University, Karachi, Pakistan, Email:

Author info »

Description

Healthcare interventions are essential in developing patient outcomes and Quality of Life (QoL). A growing focus on patientcentered care underscores improving not just clinical outcomes but also the overall well-being of individuals. Effective healthcare interventions aim to address various aspects of patients' lives, from managing chronic diseases to enhancing mental and emotional well-being. However, while these interventions can improve health, they also come with potential challenges, particularly Drug-Related Problems (DRPs). This article explores the multifaceted impact of healthcare interventions on QoL and how addressing DRPs plays a pivotal role in improving patient outcomes [1].

Healthcare interventions and QoL

Healthcare interventions include a diverse range of actions aimed at improving health, including medications, surgeries, therapies, and lifestyle modifications. The success of these interventions is often measured by their ability to improve clinical outcomes like reduced mortality rates, disease remission, and symptom management. However, a comprehensive evaluation of healthcare interventions must also consider their effects on QoL, which refers to a patient's physical, psychological, and social wellbeing [2].

Physical well-being

One of the most direct impacts of healthcare interventions is on physical health. For example, interventions such as joint replacement surgeries or cancer treatments can relieve pain, restore mobility, and extend life expectancy [3]. However, QoL assessments must go beyond these immediate clinical benefits to consider factors such as side effects, recovery time, and the patient's ability to perform daily activities post-intervention. Interventions that reduce pain or disability often enhance the patient’s physical comfort, but they can also lead to complications or limitations that must be managed.

Psychological well-being

The psychological aspect of QoL is another important consideration. Healthcare interventions can reduce stress, anxiety, and depression by effectively managing diseases and symptoms. For instance, successful treatment of chronic conditions like diabetes or hypertension can alleviate patients' concerns about long-term health risks, enhancing their mental health [3-5]. However, some interventions, particularly those involving chronic medication use or invasive procedures, may cause psychological stress due to the burden of continuous treatment or fear of recurrence.

Social well-being

Interventions that improve physical and psychological health can also positively affect social well-being, allowing patients to engage more fully in personal relationships and societal activities. For instance, improving mobility through physical therapy or surgery can enable patients to return to work or resume hobbies, contributing to a sense of normalcy and social connection. However, the financial burden of some healthcare interventions, particularly high-cost treatments, can strain social connections and reduce overall QoL if patients experience economic difficulties as a result.

Addressing drug-related problems

While healthcare interventions, particularly pharmacological treatments, can significantly improve QoL, they often lead to Drug-Related Problems (DRPs). DRPs refer to any adverse event or issue that arises from the use of medication, affecting the efficacy of the treatment or the patient’s overall well-being. Common DRPs include drug interactions, side effects, noncompliance, and improper dosing.

Strategies to address DRPs

Given the prevalence and potential severity of DRPs, addressing these issues is critical to maximizing the benefits of healthcare interventions and enhancing QoL. Several strategies can be employed to minimize the impact of DRPs on patients.

Medication Therapy Management (MTM)

MTM is a systematic approach to managing and optimizing drug therapies. It involves a thorough review of a patient’s medications to identify and resolve DRPs. MTM services often include patient education, regular monitoring, and collaboration with healthcare providers to ensure medications are safe and effective [6,7]. By addressing potential DRPs early, MTM can prevent negative outcomes, reduce hospitalizations, and improve patient adherence, ultimately enhancing QoL.

Patient education and counseling

Educating patients about their medications is essential in preventing DRPs. Patients should be informed about the purpose of their medications, possible side effects, and the importance of adherence. This can empower them to manage their treatment better, recognize early signs of DRPs, and seek help before issues escalate [8].

Pharmacovigilance programs

Pharmacovigilance involves the detection, assessment, and prevention of ADRs and other drug-related problems [2,9]. By monitoring medications post-market, healthcare systems can identify trends in ADRs, allowing for timely interventions to protect patients. Such programs play a major role in improving the safety and efficacy of healthcare interventions and mitigating their impact on QoL.

Collaborative care models

Collaboration between healthcare professionals-such as physicians, pharmacists, and nurses‑is essential for managing DRPs effectively. In a collaborative care model, healthcare providers work together to monitor patients’ medication regimens, identify potential DRPs, and adjust treatments as necessary [5,10]. This multidisciplinary approach ensures that patients receive the most appropriate care, improving both clinical outcomes and QoL.

Conclusion

Healthcare interventions play a vital role in enhancing patient QoL by improving physical, psychological, and social well-being. However, the potential for drug-related problems must be carefully managed to ensure that these interventions deliver their full benefits without compromising patient safety or quality of life. By addressing DRPs through strategies like MTM, patient education, pharmacovigilance, and collaborative care models, healthcare providers can optimize treatment outcomes, reduce risks, and contribute to a more holistic improvement in patient well-being. Ultimately, the successful management of both healthcare interventions and DRPs is essential for improving patient outcomes and QoL.

References

1. Visacri MB, Figueiredo IV, Lima T de M. Role of pharmacist during the COVID-19 pandemic: A scoping review. Res Social Adm Pharm. 2021;17(1):1799-1806.

   [Crossref] [Google Scholar] [PubMed]

2. Carnevale JB, Hatak I. Employee adjustment and well-being in the era of COVID-19: Implications for human resource management. J Bus Res. 2020;116:183-187.

   [Crossref] [Google Scholar] [PubMed]

3. Dawoud D. Emerging from the other end: Key measures for a successful COVID-19 lockdown exit strategy and the potential contribution of pharmacists. Res Social Adm Pharm. 2021;17(1):1950-1953.

   [Crossref] [Google Scholar] [PubMed]

4. Atif M, Malik I, Mushtaq I, Asghar S. Medicines shortages in Pakistan: A qualitative study to explore current situation, reasons and possible solutions to overcome the barriers. BMJ Open. 2019;9(9):e027028.

   [Crossref] [Google Scholar] [PubMed]

5. Barello S, Palamenghi L, Graffigna G. Empathic communication as a â??risky strengthâ? for health during the COVID-19 pandemic: The case of frontline Italian healthcare workers. Patient Educ Couns. 2020;103(10):2200.

   [Crossref] [Google Scholar] [PubMed]

6. Aruru M, Truong HA, Clark S. Pharmacy Emergency Preparedness and Response (PEPR): A proposed framework for expanding pharmacy professionalsâ?? roles and contributions to emergency preparedness and response during the COVID-19 pandemic and beyond. Res Social Adm Pharm. 2021;17(1):1967-1977.

   [Crossref] [Google Scholar] [PubMed]

7. Gueiros LA, Melo TS, Carrard VC. A simple tool to a complex reality-WhatsApp use in a developing country during COVID-19 pandemic. Oral Dis. 2021;27(S3):796-797.

   [Crossref] [Google Scholar] [PubMed]

8. Gan WH, Lim JW, Koh D. Preventing intra hospital infection and transmission of Coronavirus disease 2019 in health care workers. Saf Health Work. 2020;11(2):241-243.

   [Crossref] [Google Scholar] [PubMed]

9. Liu S, Luo P, Tang M, Hu Q, Polidoro JP, Sun S, et al. Providing pharmacy services during the Coronavirus pandemic. Int J Clin Pharm. 2020;42(2):299-304.

   [Crossref] [Google Scholar] [PubMed]

10. Bukhari N, Rasheed H, Nayyer B, Babar ZUD. Pharmacists at the frontline beating the COVID-19 pandemic. J Pharm Policy Pract. 2020;13(1):1-4.

    [Crossref] [Google Scholar] [PubMed]